Peter Edman
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Advanced Drug Delivery Systems 33
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 15
- Co-authors
- Ingvar Sjöholm (17 shared papers)Erik Björk (9 shared papers)Per Artursson (12 shared papers)Ola Camber (9 shared papers)Bo Ekman (1 shared paper)Robert Gurny (3 shared papers)Lars Rydén (1 shared paper)Jan L. E. Ericsson (2 shared papers)
- Journals
- International Journal of Pharmaceutics (15 papers)Journal of Pharmaceutical Sciences (11 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)Journal of Controlled Release (3 papers)Life Sciences (2 papers)
- Partner nations
- SwedenSwitzerlandNorway
In The Last Decade
Peter Edman
51 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 73
- Pharmaceutical Science 963
- Molecular Medicine 168
- Biomaterials 232
- Immunology 70
- Ophthalmology 29
Countries citing papers authored by Peter Edman
This map shows the geographic impact of Peter Edman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Edman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Edman more than expected).
Fields of papers citing papers by Peter Edman
This network shows the impact of papers produced by Peter Edman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Edman. The network helps show where Peter Edman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Edman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 138 | |
| 2 | 1984 | 114 | |
| 3 | 1987 | 96 | |
| 4 | 1988 | 93 | |
| 5 | 1990 | 83 | |
| 6 | 1992 | 75 | |
| 7 | 1992 | 68 | |
| 8 | 1995 | 58 | |
| 9 | 1983 | 51 | |
| 10 | 1979 | 50 | |
| 11 | 1995 | 44 | |
| 12 | 1987 | 43 | |
| 13 | 1987 | 38 | |
| 14 | 1990 | 35 | |
| 15 | 1989 | 32 | |
| 16 | 1991 | 29 | |
| 17 | 1992 | 29 | |
| 18 | 1986 | 28 | |
| 19 | 1984 | 26 | |
| 20 | 1987 | 26 |
About Peter Edman
Peter Edman is a scholar working on Pharmaceutical Science, Biomaterials, Biochemistry, Molecular Medicine and Immunology, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (33 papers), Nanoparticle-Based Drug Delivery (15 papers), Enzyme Catalysis and Immobilization (7 papers), Amino Acid Enzymes and Metabolism (4 papers), Hydrogels: synthesis, properties, applications (3 papers), Immunotherapy and Immune Responses (3 papers), Autophagy in Disease and Therapy (2 papers) and Ocular Surface and Contact Lens (2 papers). The work is most often cited by research in Pharmaceutical Science (963 citations), Molecular Medicine (168 citations), Biomaterials (232 citations), Immunology (70 citations) and Ophthalmology (29 citations). Peter Edman has collaborated with scholars based in Sweden, Switzerland and Norway. Frequent co-authors include Ingvar Sjöholm, Erik Björk, Per Artursson, Ola Camber, Bo Ekman, Robert Gurny, Lars Rydén, Jan L. E. Ericsson, Sivert Bjurström and C G Wilson. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Journal of Pharmacology and Experimental Therapeutics, Journal of Controlled Release and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.